EUVIMEDEUVIMED entdecken
Crossref

Beyond the cancer cell: What the 2026 Hallmarks update means for precision oncology

Dirk Geerts

Eurasian Journal of Medicine and Oncology · 18.11.2026 · 026440606

DOI: 10.36922/ejmo026440606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 18.11.2026. Verfasst von Dirk Geerts.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Geerts, D. (2026). Beyond the cancer cell: What the 2026 Hallmarks update means for precision oncology. Eurasian Journal of Medicine and Oncology, 0(0), 026440606. https://doi.org/10.36922/ejmo026440606

Vancouver

Geerts D. Beyond the cancer cell: What the 2026 Hallmarks update means for precision oncology. Eurasian Journal of Medicine and Oncology. 2026;0(0):026440606. doi:10.36922/ejmo026440606

BibTeX
@article{Geerts2026,
  author = {Geerts, Dirk},
  title = {Beyond the cancer cell: What the 2026 Hallmarks update means for precision oncology},
  journal = {Eurasian Journal of Medicine and Oncology},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {026440606},
  doi = {10.36922/ejmo026440606}
}
Kostenlos starten →